<DOC>
	<DOCNO>NCT02422446</DOCNO>
	<brief_summary>This pilot trial seek obtain preliminary data effect eicosapentaenoic acid ( EPA ) ( 4g/d ) endothelial function measure via endopat2000 12 week intervention among adult elevate triglyceride type 2 diabetes .</brief_summary>
	<brief_title>Effects Eicosapentaenoic Acid Endothelial Function Diabetic Subjects</brief_title>
	<detailed_description>Thirty adult age 30-75 randomize either 4 g/d eicosapentaenoic acid drug 12 week . Endothelial function measure baseline 12 week . secondary aim , evaluate effect eicosapentaenoic acid ( EPA ) plasma level c-reactive protein , oxidize low-density lipoprotein cholesterol , endothelin-1 .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Eicosapentaenoic acid ethyl ester</mesh_term>
	<criteria>Age 30+ year Hypertriglyceridemia ( 150400 mg/dl ) Statin use least six month time screen Type 2 diabetes treat diet and/or oral hypoglycemic agent diagnose 1+ year Ability provide inform consent provide blood sample Willingness abstain fish oil , EPA , counter niacin , omega3 fatty acid supplement study period ( 12 week ) Ability travel study site Brigham Women 's Hospital 3 study visit Reactive hyperemia index ( RHI ) â‰¤ 2.0 Eating disorder heavy drinker Treatment chronic prescription pharmacotherapy metabolic cardiovascular disease management risk factor modification Pregnant lactate woman Statin use &lt; 6 month time screen Allergy EPA , fish oil , omega3 fatty acid Current use insulin , cyclophosphamide , estrogen , fibrates , niacin , hormone replacement therapy , testosterone , oral contraceptive , growth hormone , insulinlike growth factor1 , systemic steroid . Inability provide inform consent blood sample History prevalent diagnosis cancer , asthma , kidney insufficiency , stroke , seizure , allergic disorder , congestive heart failure Diagnosis diabetes &lt; 1 year prior enrollment Intention move great Boston area within one year Current use omega3 supplement , fish oil , &gt; 2 serving fish per week Bleeding disorder uncontrolled endocrine ( i.e. , thyroid ) metabolic disorder Treatment blood thin drug ( i.e . warfarin clopidogrel ) Major surgical operation 3 month screen Organ transplantation Current participation another trial plan study Inability give inform consent travel study center Brigham Women 's Hospital RHI &gt; 2.0 Triglycerides &lt; 150 mg/dl &gt; 400 mg/dl Body mass index 40+ kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Endothelial function</keyword>
	<keyword>Eicosapentaenoic acid</keyword>
	<keyword>Triglycerides</keyword>
</DOC>